Geneva Capital Management LLC has filed a Form 13F-HR with the U.S. Securities and Exchange Commission, disclosing its equity holdings as of the close of business on September 30, 2026. The filing details the firm's investment positions across a broad range of public companies.
The report lists the firm's contact information, including its address at 411 East Wisconsin Avenue, Suite 2320, in Milwaukee, Wisconsin, and identifies John G. Davis as the Deputy Chief Compliance Officer responsible for the filing.
The portfolio includes a diverse mix of common stock holdings. Notable positions include significant stakes in companies such as AppFolio Inc., with 26,220 shares; Bio-Techne Corp., with 654,745 shares; and Healthequity Inc., with 796,512 shares. Other listed holdings include Align Technology Inc., Alphabet Inc., Amphenol Corporation, and API Group Corp.
The filing also lists several exchange-traded funds (ETFs) within the portfolio, including the Invesco Exchange Traded Fund Trust II S&P SMLCP INDL ETF, the Invesco Exchange-Traded Fund Trust S&P500 EQL STP ETF, and various iShares ETFs tracking sectors such as industrials, home construction, and self-driving vehicles.
